Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study
Background Despite recent progress in the field of genetics, sporadic late-onset (> 40 years) cerebellar ataxia (SLOCA) etiology remains frequently elusive, while the optimal diagnostic workup still needs to be determined. We aimed to comprehensively describe the causes of SLOCA and to discuss th...
Gespeichert in:
Veröffentlicht in: | Journal of neurology 2022-12, Vol.269 (12), p.6354-6365 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Despite recent progress in the field of genetics, sporadic late-onset (> 40 years) cerebellar ataxia (SLOCA) etiology remains frequently elusive, while the optimal diagnostic workup still needs to be determined. We aimed to comprehensively describe the causes of SLOCA and to discuss the relevance of the investigations.
Methods
We included 205 consecutive patients with SLOCA seen in our referral center. Patients were prospectively investigated using exhaustive clinical assessment, biochemical, genetic, electrophysiological, and imaging explorations.
Results
We established a diagnosis in 135 (66%) patients and reported 26 different causes for SLOCA, the most frequent being multiple system atrophy cerebellar type (MSA-C) (41%). Fifty-one patients (25%) had various causes of SLOCA including immune-mediated diseases such as multiple sclerosis or anti-GAD antibody-mediated ataxia; and other causes, such as alcoholic cerebellar degeneration, superficial siderosis, or Creutzfeldt–Jakob disease. We also identified 11 genetic causes in 20 patients, including
SPG7
(n = 4),
RFC1
-associated CANVAS (n = 3),
SLC20A2
(
n
= 3), very-late-onset Friedreich’s ataxia (
n
= 2), FXTAS (
n
= 2), SCA3 (
n
= 1), SCA17 (
n
= 1), DRPLA (
n
= 1),
MYORG
(
n
= 1), MELAS (
n
= 1), and a mitochondriopathy (
n
= 1) that were less severe than MSA-C (
p
|
---|---|
ISSN: | 0340-5354 1432-1459 1432-1459 |
DOI: | 10.1007/s00415-022-11253-1 |